» Articles » PMID: 32582424

An Urgent Need to Institute COVID-19 Testing in Patients with IBD Experiencing Flares

Overview
Specialty Gastroenterology
Date 2020 Jun 26
PMID 32582424
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.

Bamias G, Kokkotis G, Christidou A, Christodoulou D, Delis V, Diamantopoulou G Eur J Gastroenterol Hepatol. 2021; 33(1S Suppl 1):e810-e817.

PMID: 34402469 PMC: 8734573. DOI: 10.1097/MEG.0000000000002267.

References
1.
Mao R, Liang J, Shen J, Ghosh S, Zhu L, Yang H . Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5(5):425-427. PMC: 7103943. DOI: 10.1016/S2468-1253(20)30076-5. View

2.
Ghosh N, Premchand P . A UK cost of care model for inflammatory bowel disease. Frontline Gastroenterol. 2017; 6(3):169-174. PMC: 5369575. DOI: 10.1136/flgastro-2014-100514. View

3.
Short K, Veeris R, Leijten L, van den Brand J, Jong V, Stittelaar K . Proinflammatory Cytokine Responses in Extra-Respiratory Tissues During Severe Influenza. J Infect Dis. 2017; 216(7):829-833. DOI: 10.1093/infdis/jix281. View

4.
Russell C, Millar J, Baillie J . Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020; 395(10223):473-475. PMC: 7134694. DOI: 10.1016/S0140-6736(20)30317-2. View

5.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J . Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020; 115(5):766-773. PMC: 7172492. DOI: 10.14309/ajg.0000000000000620. View